Please login to the form below

Not currently logged in
Email:
Password:

The LionsDen Communications Award for Excellence in Payer and Policy Maker Engagement


The LionsDen Communications Award for Excellence in Payer and Policy Maker Engagement

This award recognises excellence in programmes that engage one or more key payer/stakeholder group(s) (national, regional or European) to develop and broaden debate with clinical, governmental, public and/or other stakeholders to achieve policy change that will lead to improvements in:

  • Health outcomes - delivered by challenging inequality of health outcomes, clinical care or access to medicines or services
  • Clinical practice 
  • Standards of treatment
  • Planning, coordination or delivery of services. 

Work carried out during the two-year period between January 2011 and December 2012 will be eligible.

Submissions entered previously must demonstrate how the programme has been further developed during the additional time period.

Entries are invited from:

  • Charities
  • Patient or professional associations/bodies
  • Pharmaceutical companies
  • Healthcare agencies/consultancies
  • Trade associations.

Judging criteria:

  • Analysis of the problem and evidence of customer insight
  • Quality of the strategy/tactics employed to achieve key objectives
  • Evidence of change effected through communication with national or European payers/policy makers 
  • Evidence of support from a range of interested stakeholders, e.g. healthcare professionals and patient representatives
  • Effectiveness - evidence of changed behaviours and enhanced health outcomes
  • Stakeholder/customer feedback


Sponsors

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics